May Faraj

Professor

Université de Montréal

Canada

Research Interests

Explore related searches

Professors in Canada Professors in Immunology Immunology professors in Canada

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

May Faraj is a Professor at Université de Montréal, Canada. Her research primarily focuses on the relationship between lipoproteins, adipose tissue, and inflammatory pathways, as well as the implications for diabetes risk factors. Recent articles include investigations into the effects of EPA and DHA on the NLRP3 inflammasome, as well as sex-specific models for insulin sensitivity in overweight and obese populations.

Articles (6)

Year:

2024

Year:

2023

Year:

2023

Year:

2021

Year:

2020

Year:

2020

Collaborators (3)

Maya Saleh

Full Professor of Immunology

Institut national de la recherche scientifique

CANADA

View details

Emmanuelle LOIZON

INSERM

FRANCE

View details

Jennifer Estall

Associate Research Professor

Institut de recherches cliniques de Montréal

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

May Faraj

Research Interests

Explore related searches

Contact this professor

About

Articles (6)

EPA and DHA inhibit LDL-induced upregulation of human adipose tissue NLRP3 inflammasome/IL-1β pathway and its association with diabetes risk factors

Sex-Specific Models to Predict Insulin Secretion and Sensitivity in Subjects with Overweight and Obesity

Native low-density lipoproteins are priming signals of the NLRP3 inflammasome/interleukin-1β pathway in human adipose tissue and macrophages

Lower plasma PCSK9 in normocholesterolemic subjects is associated with upregulated adipose tissue surface‐expression of LDLR and CD36 and NLRP3 inflammasome

White Adipose Tissue Surface Expression of LDLR and CD36 is Associated with Risk Factors for Type 2 Diabetes in Adults with Obesity

LDL, LDL receptors, and PCSK9 as modulators of the risk for type 2 diabetes: a focus on white adipose tissue.

Collaborators (3)

Maya Saleh

Emmanuelle LOIZON

Jennifer Estall

Make your next move.